Emma L. Scotter

4.6k citations

48 papers · 2.7k indexed · h-index 24

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research 26
- Neuroinflammation and Neurodegeneration Mechanisms 10
- Barrier Structure and Function Studies 6
- Parkinson's Disease Mechanisms and Treatments 5
Neurology top 1%
- Amyotrophic Lateral Sclerosis Research 26
- Neuroinflammation and Neurodegeneration Mechanisms 10
- Barrier Structure and Function Studies 6
- Parkinson's Disease Mechanisms and Treatments 5
Genetics top 1%
- Neurogenetic and Muscular Disorders Research 20
Cellular and Molecular Neuroscience top 5%
- Genetic Neurodegenerative Diseases 6
Biological Psychiatry top 10%
Physiology
- Alzheimer's disease research and treatments 7
Molecular Biology
- RNA Research and Splicing 5

Co-authors: Christopher E. Shaw Mike Dragunow Han-Jou Chen Michelle Glass Caroline Vance Richard L. M. Faull Agnes L. Nishimura E. Scott Graham
Cited by: Neurology Genetics
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)PLoS ONE (1 paper)
Partner nations: New Zealand United Kingdom United States

In The Last Decade

Emma L. Scotter

47 papers receiving 2.7k citations

Peers

Countries citing papers authored by Emma L. Scotter

Since Specialization

Citations

This map shows the geographic impact of Emma L. Scotter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma L. Scotter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma L. Scotter more than expected).

Fields of papers citing papers by Emma L. Scotter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma L. Scotter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma L. Scotter. The network helps show where Emma L. Scotter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emma L. Scotter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emma L. Scotter Line = papers co-authored together Emma L. Scotter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The genetics of motor neuron disease in New Zealand Journal of the Neurological Sciences ·Miran Mrkela,Miriam Rodrigues,Serey Naidoo,Jules B. L. Devaux,Siobhan E. Kirk,Chitra Vinnakota,Christina M. Buchanan,Dympna Mulroy,H. Fraser,Jessie C. Jacobsen,Hannah Wyatt,Kylie M. Drake,Elsa Parker,Howard Potter,Lyndal Henden,Emily P. McCann,Kelly L. Williams,Anjali K. Henders,Richard Roxburgh,Emma L. Scotter	2025	0
2	Huntingtin inclusion bodies have distinct immunophenotypes and ubiquitination profiles in the Huntington’s disease human cerebral cortex Scientific Reports ·Molly E. V. Swanson,Adelie Y. S. Tan,Lynette J. Tippett,Clinton Turner,Maurice A. Curtis,Emma L. Scotter,Hilal A. Lashuel,Mike Dragunow,Richard L. M. Faull,Helen C. Murray,Malvindar K. Singh‐Bains	2025	1
3	Distribution of ubiquilin 2 and TDP‐43 aggregates throughout the CNS in UBQLN2 p.T487I‐linked amyotrophic lateral sclerosis and frontotemporal dementia Brain Pathology ·Laura R. Nementzik,Kyrah M. Thumbadoo,Helen C. Murray,David F. Gordon,Shu Yang,Ian P. Blair,Clinton Turner,Richard L. M. Faull,Maurice A. Curtis,Catriona McLean,Garth A. Nicholson,Molly E. V. Swanson,Emma L. Scotter	2023	7
4	Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 – meta-analysis and interactive graphical database Disease Models & Mechanisms ·Maize C. Cao,Emma L. Scotter	2022	12
5	TDP-43 pathology: From noxious assembly to therapeutic removal Progress in Neurobiology ·Sean S. Keating,Rebecca San Gil,Molly E. V. Swanson,Emma L. Scotter,Adam K. Walker	2022	52
6	The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes Molecular and Cellular Neuroscience ·Emma L. Scotter,Maize C. Cao,Deidre Jansson,Justin Rustenhoven,Leon Smyth,Miranda Aalderink,Andrew Siemens,Vicky Fan,Jane Y. Wu,Edward Mee,Richard L. M. Faull,Mike Dragunow	2022	8
7	Single-cell image analysis reveals a protective role for microglia in glioblastoma Neuro-Oncology Advances ·Zoe Woolf,Molly E. V. Swanson,Leon Smyth,Edward Mee,Patrick Schweder,Peter Heppner,Bernard J H Kim,Clinton Turner,Robyn Oldfield,Maurice A. Curtis,Richard L. M. Faull,Emma L. Scotter,Thomas Park,Michael Dragunow	2021	35
8	Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus Communications Biology ·Deidre Jansson,Birger Victor Dieriks,Justin Rustenhoven,Leon Smyth,Emma L. Scotter,Miranda Aalderink,Sheryl Feng,Rebecca Johnson,Patrick Schweder,Edward Mee,Peter Heppner,Clinton Turner,Maurice A. Curtis,Richard L. M. Faull,Mike Dragunow	2021	22
9	Blood-spinal cord barrier leakage is independent of motor neuron pathology in ALS Acta Neuropathologica Communications ·Sarah L. Waters,Molly E. V. Swanson,Birger Victor Dieriks,Yibin B. Zhang,Natasha L. Grimsey,Helen C. Murray,Clinton Turner,Henry J. Waldvogel,Richard L. M. Faull,Jiyan An,Robert Bowser,Maurice A. Curtis,Mike Dragunow,Emma L. Scotter	2021	32
10	Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis Acta Neuropathologica Communications ·Molly E. V. Swanson,Emma L. Scotter,Leon Smyth,Helen C. Murray,Brigid Ryan,Clinton Turner,Richard L. M. Faull,Mike Dragunow,Maurice A. Curtis	2020	53
11	ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function Proceedings of the National Academy of Sciences ·Josephine J. Wu,Ashley Cai,Jessie E. Greenslade,Nicole Higgins,Cong Fan,Nhat T. T. Le,Micaela Tatman,Alexandra M. Whiteley,Miguel A. Prado,Birger Victor Dieriks,Maurice A. Curtis,Christopher E. Shaw,Teepu Siddique,Richard L. M. Faull,Emma L. Scotter,Daniel Finley,Mervyn J. Monteiro	2020	61
12	PU.1 regulates Alzheimer’s disease-associated genes in primary human microglia Molecular Neurodegeneration ·Justin Rustenhoven,Amy M. Smith,Leon Smyth,Deidre Jansson,Emma L. Scotter,Molly E. V. Swanson,Miranda Aalderink,Natacha Coppieters,Pritika Narayan,Renée R. Handley,Christopher C. Overall,Thomas Park,Patrick Schweder,Peter Heppner,Maurice A. Curtis,Richard L. M. Faull,Mike Dragunow	2018	100
13	An anti-inflammatory role for C/EBPδ in human brain pericytes Scientific Reports ·Justin Rustenhoven,Emma L. Scotter,Deidre Jansson,Dan T. Kho,Robyn Oldfield,Peter S. Bergin,Edward Mee,Richard L. M. Faull,Maurice A. Curtis,E. Scott Graham,Thomas Park,Mike Dragunow	2015	46
14	Novel mutations support a role for Profilin 1 in the pathogenesis of ALS Neurobiology of Aging ·Bradley Smith,Caroline Vance,Emma L. Scotter,Claire Troakes,Chun Hao Wong,Simon Topp,Satomi Maekawa,Andrew King,Jacqueline C. Mitchell,Karan Lund,Ammar Al‐Chalabi,Nicola Ticozzi,Vincenzo Silani,Peter C. Sapp,Robert H. Brown,John E. Landers,Safa Al‐Sarraj,Christopher E. Shaw	2014	81
15	Differential roles of the ubiquitin proteasome system (UPS) and autophagy in the clearance of soluble and aggregated TDP-43 species Journal of Cell Science ·Emma L. Scotter,Caroline Vance,Agnes L. Nishimura,Youn‐Bok Lee,Han-Jou Chen,Hazel Urwin,Valentina Sardone,Jacqueline C. Mitchell,Boris Rogelj,David C. Rubinsztein,Christopher E. Shaw	2014	211
16	ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules Human Molecular Genetics ·Caroline Vance,Emma L. Scotter,Agnes L. Nishimura,Claire Troakes,Jacqueline C. Mitchell,Claudia Kathe,Hazel Urwin,Catherine Manser,Christopher C.J. Miller,Tibor Hortobágyi,Mike Dragunow,Boris Rogelj,Christopher E. Shaw	2013	191
17	Neuromuscular disease: new insights and avenues for therapy The Lancet Neurology ·Emma L. Scotter,Christopher E. Shaw	2012	3
18	The therapeutic potential of G-protein coupled receptors in Huntington's disease Pharmacology & Therapeutics ·Megan J. Dowie,Emma L. Scotter,Emanuela Molinari,Michelle Glass	2010	20
19	Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! Journal of Neuroscience Methods ·Natasha L. Grimsey,Catherine E. Goodfellow,Emma L. Scotter,Megan J. Dowie,Michelle Glass,E. Scott Graham	2008	100
20	Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway Journal of Biological Chemistry ·E. Scott Graham,Nicola Ball,Emma L. Scotter,Pritika Narayan,Mike Dragunow,Michelle Glass	2006	52

About Emma L. Scotter

Emma L. Scotter is a scholar working on Neurology, Genetics and Neurology, having authored 48 papers that have together received 2.7k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (26 papers), Neurogenetic and Muscular Disorders Research (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Alzheimer's disease research and treatments (7 papers), Genetic Neurodegenerative Diseases (6 papers), Barrier Structure and Function Studies (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and RNA Research and Splicing (5 papers). The work is most often cited by research in Neurology (1.3k citations), Neurology (609 citations) and Genetics (741 citations). Emma L. Scotter has collaborated with scholars based in New Zealand, United Kingdom and United States. Frequent co-authors include Christopher E. Shaw, Mike Dragunow, Han-Jou Chen, Michelle Glass, Caroline Vance, Richard L. M. Faull, Agnes L. Nishimura, E. Scott Graham, Jacqueline C. Mitchell and Boris Rogelj. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact